leading provider of tms therapy. fda-cleared & proven treatment for depression. non-invasive, non-sedating, no drug related side effects. we can help!
Company profile
Ticker
GBNHF
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
resTORbio, Inc.
SEC CIK
Corporate docs
Subsidiaries
Where Incorporated • Check Five Staffing, LLC • TMS NeuroHealth Centers Inc. • TMS NeuroHealth Centers Services LLC • Greenbrook TMS Austin Central LLC • Greenbrook TMS Cary LLC • Greenbrook TMS Chapel Hill LLC • Greenbrook TMS Christiansburg LLC • Greenbrook TMS Cleveland LLC • Greenbrook TMS Easton LLC ...
GBNHF stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
16 Oct 24
8-K
Greenbrook Announces Conversion of Subordinated Convertible Notes
4 Oct 24
8-K
Entry into a Material Definitive Agreement
20 Sep 24
8-K
Regulation FD Disclosure
17 Sep 24
8-K
Entry into a Material Definitive Agreement
6 Sep 24
8-K
Entry into a Material Definitive Agreement
21 Aug 24
10-Q
2024 Q2
Quarterly report
13 Aug 24
8-K
GREENBROOK TMS REPORTS SECOND QUARTER operational and FINANCIAL RESULTS
13 Aug 24
8-K
Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge
12 Aug 24
8-K
Greenbrook Announces Settlement of Lawsuit with Benjamin Klein
9 Aug 24
Transcripts
GBNHF
Earnings call transcript
2023 Q3
9 Nov 23
GBNHF
Earnings call transcript
2023 Q2
15 Aug 23
GBNHF
Earnings call transcript
2022 Q3
9 Nov 22
GBNHF
Earnings call transcript
2022 Q2
7 Aug 22
GBNHF
Earnings call transcript
2022 Q1
16 May 22
GBNHF
Earnings call transcript
2021 Q4
1 Apr 22
GBNHF
Earnings call transcript
2021 Q3
10 Nov 21
GBNHF
Earnings call transcript
2021 Q2
6 Aug 21
GBNHF
Earnings call transcript
2021 Q1
17 May 21
Latest ownership filings
SC 13D/A
Madryn Asset Management, LP
27 Jun 24
SC 13D/A
Greybrook Health Inc.
27 Jun 24
SC 13D/A
Madryn Asset Management, LP
13 Jun 24
SC 13D/A
Madryn Asset Management, LP
4 Jun 24
4
Andrew Crish
30 May 24
4
Peter Casimir Willett
30 May 24
SC 13D/A
Madryn Asset Management, LP
28 May 24
SC 13D/A
Madryn Asset Management, LP
22 May 24
SC 13D/A
Madryn Asset Management, LP
16 May 24
SC 13D/A
Madryn Asset Management, LP
13 May 24
Financial summary
Quarter (USD) | Jun 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.35 mm | 3.35 mm | 3.35 mm | 3.35 mm | 3.35 mm | |
Cash burn (monthly) | (no burn) | 4.15 mm | 1.04 mm | 4.04 mm | 1.01 mm | |
Cash used (since last report) | n/a | 15.23 mm | 3.81 mm | 14.83 mm | 3.71 mm | |
Cash remaining | n/a | -11.88 mm | -459.38 k | -11.48 mm | -359.20 k | |
Runway (months of cash) | n/a | -2.9 | -0.4 | -2.8 | -0.4 |
Institutional ownership, Q2 2024
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 36.01 mm |
Total shares | 74.74 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Greybrook Health | 45.72 mm | $0.00 |
Vamvakas Family Trust | 19.65 mm | $5.21 mm |
Klein Benjamin | 3.87 mm | $5.23 mm |
MSS GB SPV | 3.43 mm | $1.71 mm |
1315 Capital II | 2.07 mm | $23.86 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | Andrew Crish | Options Common Shares | Grant | Acquire A | No | No | 0.101 | 250,000 | 25.25 k | 250,000 |
1 Apr 24 | Peter Casimir Willett | Options Common Shares | Grant | Acquire A | No | No | 0.101 | 300,000 | 30.30 k | 300,000 |